Search - tctmd.com

Displaying 121 - 140 of 294

Sort: Relevancy | Date

Presentation THT 2025

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Presenter: Barry Borlaug

February 11, 2025

Presentation THT 2025

Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis

Presenter: Gabriel Sayer

February 11, 2025

Presentation THT 2025

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Presenter: Javed Butler

February 11, 2025

Presentation THT 2025

Changes in Seated Pulmonary Artery Pressure in Response to Titration of Heart Failure Medications During Ambulatory Monitoring

Presenter: Sandip Zalawadiya

February 11, 2025

Presentation THT 2025

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) – The FASTR Trial

Presenter: James Udelson

February 11, 2025

Presentation THT 2025

Robotic Surgical Technique for Performing Heart Transplant

Presenter: Feras Khaliel

February 11, 2025

Presentation THT 2025

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

Presenter: Gregg W. Stone

February 11, 2025

Presentation THT 2025

Impact of Psychological Comorbidities on Clinical Outcomes in Heart Failure With Reduced Ejection Fraction (HFrEF)

Presenter: Jonathan Zawadzki

February 11, 2025

Presentation THT 2025

Clinical Characteristics and Predictors of Mortality in Cardiogenic Shock: A PREMIER Healthcare Database Analysis

Presenter: Joseph Ibrahim

February 11, 2025

Presentation THT 2025

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Presenter: Abduljabar Adi

February 11, 2025

Presentation THT 2025

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Presenter: Anthony Carnicelli

February 11, 2025

Presentation THT 2025

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Presenter: Jonathan Zawadzki

February 11, 2025

Presentation THT 2025

Cardiac Microcurrent Application for the Reversal of Heart Failure

Presenter: Eduardo Rame

February 11, 2025

Presentation THT 2025

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2025

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes After Interatrial Shunting in Heart Failure

Presenter: Stefan Anker

February 11, 2025

Presentation THT 2025

Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF

Presenter: Barry Borlaug

February 11, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Electrophysiological Characteristics and Clinical Outcomes of Truncal, Fascicular and Left Ventricular Septal Pacing in Patients Receiving Left Bundle Branch Area Pacing

Presenter: Shunmuga Ponnusamy

February 11, 2025

Presentation THT 2025

Strategy to Prevent Cardiogenic SHOCK: Randomised Clinical Trial (STOPSHOCK - RCT)

Presenter: Allan Böhm

February 11, 2025

Presentation THT 2025

Salt and HF: Addressing the Controversies of Molecular Mechanisms, Physiology, Clinical Data

Presenter: Jeffrey Testani

February 11, 2025

Presentation THT 2025

Drug Therapy to Improve Shock Outcomes: The Emerging DPP3 Story

Presenter: Mahir Karakas

February 11, 2025

Advertisement

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Changes in Seated Pulmonary Artery Pressure in Response to Titration of Heart Failure Medications During Ambulatory Monitoring

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) – The FASTR Trial

Robotic Surgical Technique for Performing Heart Transplant

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

Impact of Psychological Comorbidities on Clinical Outcomes in Heart Failure With Reduced Ejection Fraction (HFrEF)

Clinical Characteristics and Predictors of Mortality in Cardiogenic Shock: A PREMIER Healthcare Database Analysis

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Cardiac Microcurrent Application for the Reversal of Heart Failure

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes After Interatrial Shunting in Heart Failure

Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF

Special Late-Breaking Clinical Science Abstract: Electrophysiological Characteristics and Clinical Outcomes of Truncal, Fascicular and Left Ventricular Septal Pacing in Patients Receiving Left Bundle Branch Area Pacing

Strategy to Prevent Cardiogenic SHOCK: Randomised Clinical Trial (STOPSHOCK - RCT)

Salt and HF: Addressing the Controversies of Molecular Mechanisms, Physiology, Clinical Data

Drug Therapy to Improve Shock Outcomes: The Emerging DPP3 Story

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content